Recent developments in antivirals against hepatitis B virus.

Abstract

Chronic hepatitis B virus (HBV) infection (CHB) is a major cause of cirrhosis and hepatocellular carcinoma (HCC). Although the availability of HBV vaccines effectively reduces the incidence of HBV infection, the healthcare burden from CHB remains high. Several antiviral agents, such as (pegylated-) interferon-α and nucleos(t)ide analogs are approved by US… (More)
DOI: 10.1016/j.virusres.2015.12.014

Topics

Cite this paper

@article{Wang2016RecentDI, title={Recent developments in antivirals against hepatitis B virus.}, author={Ya-juan Wang and Li Yang and Jian-ping Zuo}, journal={Virus research}, year={2016}, volume={213}, pages={205-213} }